France-based Gecko Biomedical SAS has obtained €22.5 million in equity financing from Sofinnova Partners, Bpifrance and others in order to advance its medical device for tissue reconstruction, which is based on proprietary biopolymers. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
